Publikationen:

• Stefanov T, Blüher M, Vekova A, Bonova I, Tzvetkov S, Kurktschiev D, Temelkova-Kurktschiev T. Circulating chemerin decreases in response to a combined strength and endurance training. Endocrine 2014; 45(3): 382-91


• Temelkova-Kurktschiev T, Stefanov T, Koehler C, Henkel E, Schaper F, Hanefeld M. Physical activity is strongly inversely related to post-challenge plasma glucose and glycemic spikes in a risk population for type 2 diabetes. Folia Med (Plovdiv) 2013; 55(2): 33-42


• Stefanov T, Vekova A, Bonova I, Tzvetkov S, Kurktschiev D, Blüher M, Temelkova-Kurktschiev T. Effects of supervised vs non-supervised combined aerobic and resistance exercise programme on cardiometabolic risk factors. Cent Eur J Public Health 2013;21(1): 8-16


• Stefanov T, Temelkova-Kurktschiev T, Koehler C, Henkel E, Schaper F, Hanefeld M. Association of physical activity with insulin resistance, subclinical inflammation, coagulation, and fibrinolytic biomarkers among population at high risk for type 2 diabetes. Folia Medica (Plovdiv) 2012; 54(2):32-39


• Temelkova-Kurktschiev T, Stefanov Ts. Lifestyle and genetics in obesity and type 2 diabetes. Exp Clin Endocrinol Diabetes 2012; 120(1): 1-6


• Stefanov TS, Temelkova-Kurktschiev TS. The metabolic syndrome in Bulgaria. Folia Medica (Plovdiv) 2011; 53(4): 5-14


• Stefanov Ts, Vekova A, Kurktschiev D, Vladimirova-Kitova L, Temelkova-Kurktschiev T. Relationship of physical activity and eating behavior with obesity and type 2 diabetes mellitus: Sofia Lifestyle (SLS) study. Folia Medica Plovdiv 2011; 53(1): 11-18


• Temelkova-Kurktschiev T. Diabetes Präventionspraxis – Erfahrungen aus populationsbasierter physischer Aktivität. Diabetes, Stoffwechsel und Herz 2010; 19(5): 60


• Gkrania-Klotsas E, Ye Z, Cooper AJ, Sharp SJ, Luben R, Biggs ML, Chen LK, Gokulakrishnan K, Hanefeld M, Ingelsson E, Lai WA, Lin SY, Lind L, Lohsoonthorn V, Mohan V, Muscari A, Nilsson G, Ohrvik J, Chao Qiang J, Jenny NS, Tamakoshi K, Temelkova-Kurktschiev T, Wang YY, Yajnik CS, Zoli M, Khaw KT, Forouhi NG, Wareham NJ, Langenberg C. Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies. PLoS One 2010; 5(10): e13405


• Temelkova-Kurktschiev T, Kurktschiev D, Vladimirova-Kitova L, Vaklinova I, Bonov P. High prevalence of the metabolic syndrome in populations at high and low cardiovascular risk in Bulgaria. Journal of Diabetology 2010; 1: 3-10


• Temelkova-Kurktschiev T, Kurktschiev D, Henkel E, Köhler C, Schaper F, Hanefeld M. Low physical activity is associated with increased insulin resistance. Sport and Science 2010; 2: 25-36


• Stefanov Ts, Temelkova-Kurktschiev T. Lifestyle and genetics in the development of type 2 diabetes. Kinesitherapy 2010; 2: 5-12


• Temelkova-Kurktschiev T. Physical activity in the prevention of type 2 diabetes mellitus. Kinesitherapy 2009; 4: 1-18


• Stefanov Ts, Temelkova-Kurktschiev T. The obesity epidemic- effect of physical activity. Sport and Science 2009; 6: 70-78


• Temelkova-Kurktschiev T, Kurktschiev D, Vladimirova-Kitova L, Vaklinova I, Todorova B. Prevalence and type of dyslipidaemia in a population at risk for cardiovascular death in Bulgaria. Folia Medica Plovdiv 2009; 2: 26-33


• Kurktschiev D, Vladimirova-Kitova L, Todorova B, Kaikkonen J, Temelkova-Kurktschiev T. Cardiovascular risk factors in type 2 diabetic patients in Bulgaria. Folia Medica Plovdiv 2009; 2: 19-25


• Temelkova-Kurktschiev T, Kurktschiev D, Vladimirova-Kitova L, Koehler C, Henkel E, Todorova B, Schaper F, Fuecker K, Hanefeld M. Pulse pressure is a strong predictor of cardiovascular risk: data of the RIAD and SMS studies. Folia Medica Plovdiv 2009; 1: 34-41


• Kurktschiev D, Lasavičiūtė S, Vaklinova I, Dasheva D, Griškūnaitė A, Temelkova-Kurktschiev T. Relationship between physical activity, obesity and type 2 diabetes mellitus. Sport and Science 2008; 6: 46-53


• Temelkova-Kurktschiev T, Kurktschiev D, J. Kaikkonen, I. Vaklinova, B. Todorova. Overweight and obesity among patients with history of myocardial infarction, hypertension and type 2 diabetes mellitus in Bulgaria. Heart and Lung 2008; 14: 31-41


• Кurktschiev D. The role of physical activity in combating cardiovascular disease. Sport and Science 2008; 1: 87-93


• Temelkova-Kurktschiev T. Physical activity in the prevention and treatment of cardiovascular disease. Diabetes, Stoffwechsel und Herz 2007; 5: 335-341


• Temelkova-Kurktschiev T, Schnell O. Postprandial glucose level and cardiovascular risk. Bulgarian Cardiology 2006; 4: 157-161


• Tsuchiya T, Schwarz PE, Bosque-Plata LD, Geoffrey Hayes M, Dina C, Froguel P, Wayne Towers G, Fischer S, Temelkova-Kurktschiev T, Rietzsch H, Graessler J, Vcelák J, Palyzová D, Selisko T, Bendlová B, Schulze J, Julius U, Hanefeld M, Weedon MN, Evans JC, Frayling TM, Hattersley AT, Orho-Melander M, Groop L, Malecki MT, Hansen T, Pedersen O, Fingerlin TE, Boehnke M, Hanis CL, Cox NJ, Bell GI. Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses. Mol Genet Metab 2006; 89(1-2): 174-84


• Temelkova-Kurktschiev T, Koehler C, Henkel E, Vladimirova-Kitova L, Kurktschiev D, Todorova B, Schaper F, Fuecker K, Hanefeld M. Pulse pressure as a risk factor for cardiovascular disease in Saxony and Bulgaria. Bulgarian Cardiology 2006; 1: 108-113


• Kurktschiev D, Temelkova-Kurktschiev T, Koehler C, Henkel E, Hanefeld M. Relationship of fatty liver with increased carotid intima-media thickness. Heart and Lung 2006; 12: 21-30


• Temelkova-Kurktschiev T, Kurktschiev D, Vladimirova-Kitova L, Todorova B. Pulse pressure is a significant risk factor for myocardial infarction: the Sofia Metabolic Syndrome (SMS) Study. Heart and Lung 2005; 11: 1-10


• Temelkova-Kurktschiev T, Hanefeld M. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes. Exp Clin Endocrinol Diabetes 2004; 112(2): 75-79

2. Publikationen in Büchern

• Temelkova-Kurktschiev T. Treatment of hyper/dyslipidemia in diabetes mellitus. In: Treatment of hyperlipidemia. Vladimirova-Kitova L (ed.) 2010


• Temelkova-Kurktschiev T. Postprandialer Status und Gefäßrisiko. In: Fortschritte in der Therapie des Typ 2 Diabetes mit oralen Antidiabetika: Fokus Inkretinkonzept. Hanefeld M & Nauck M. (Hrsg.) Uni-Med Verlag, Bremen 2010; 42-49 (2nd edition)


• Palakarski G, Bonov P, Dasheva D, Garkov V, Pedev T, Temelkova-Kurktschiev T, Kurktschiev D. Haematological changes under the effects of training at aerobic threshold level, moderate altitude and cold conditions in high level biathlon and orienteering athletes. In: Science and Nordic Skiing (Eds. Linnamo V, Komi PV, Müller E), Oxford: Meyer&Meyer Sport UK; 2007: 249-256.


• Temelkova-Kurktschiev T, D. Kurktschiev, L. Vladimirova-Kitova, M. Nikolova, B. Todorova. Prevalence and type of hyperlipidaemia in patients with myocardial infarction, hypertension and type 2 diabetes in Bulgaria. In: Arteriosklerose: Neue Konzepte, Risikofaktoren und Targets. Heinle H, Schulte H, von Eckardstein A (Hrsg.) Tübingen 2007; 122-126


• Kurktschiev D, Todorova B, Temelkova-Kurktschiev T. Obesity as a risk factor for atherosclerosis among the Bulgarian population. Sport, Stress, Adaptation; София 2006: 557-561


• Vladimirova-Kitova L, Temelkova-Kurktschiev T, Deneva T, Nikolov F. Flow mediated vasodilation and intima-media thickness in asymptomatic patients with familial hypercholesterolemia. In: Stoffwechsel und Modifikation von Lipiden und Lipoproteinen. Heinle H, Schulte H, von Eckardstein A (Hrsg.) Tübingen 2006; 212-217


• Temelkova-Kurktschiev T, D. Kurktschiev, L. Vladimirova-Kitova, B. Todorova. Pulse pressure is an important risk factor for myocadrial infarction: the Sofia Metabolic Syndrome (SMS) Study. In: Stoffwechsel und Modifikation von Lipiden und Lipoproteinen. Heinle H, Schulte H, von Eckardstein A (Hrsg.) Tübingen 2006; 217-222


• Temelkova-Kurktschiev T, Fuecker K, Koehler C, Leonhardt W, Hanefeld M. Adiponektin- ein signifikanter unabhängiger Risikofaktor für Intima-Media-Dicke: die RIAD Studie. In: Vaskuläre Inflammation und endotheliale Dysfunktion. Heinle H, Schulte H, von Eckardstein A (Hrsg.) Tübingen 2005; 93-98


• Todorova B, Temelkova-Kurktschiev T, Kubaszek A, Koehler C, Hanefeld M, Laakso M. Association of the common polymorphisms of the plasma cell membrane glycoprotein (K121Q) gene with early atherosclerosis. Vaskuläre Inflammation und endotheliale Dysfunktion. Heinle H, Schulte H, von Eckardstein A (Hrsg.) Tübingen 2005; 48-51


• Todorova B, Temelkova-Kurktschiev T, Zacharova E, Koehler C, Hanefeld M, Laakso M. C-reactive protein (G1059C) gene and early atherosclerosis. Vaskuläre Inflammation und endotheliale Dysfunktion. Heinle H, Schulte H, von Eckardstein A (Hrsg.) Tübingen 2005; 140-143


• Kurktschiev D, Majdrakova I, Todorova B, Varbanova T, Temelkova-Kurktschiev T. Risikofaktor Hypercholesterinämie – eine hohe Dunkelziffer in Bulgarien: die SMS Studie. Vaskuläre Inflammation und endotheliale Dysfunktion. Heinle H, Schulte H, von Eckardstein A (Hrsg.) Tübingen 2005; 213-218


• Majdrakova I, Todorova B, Kurktschiev D, Varbanova T, Temelkova-Kurktschiev T. Hypertension – incidence and management in Bulgaria. The Sofia Metabolic Syndrome Study. Vaskuläre Inflammation und endotheliale Dysfunktion. Heinle H, Schulte H, von Eckardstein A (Hrsg.) Tübingen 2005; 218-221


• Temelkova-Kurktschiev T, Todorova B, Majdrakova I, Varbanova T, Kurktschiev D. Prävalenz des metabolischen Syndroms in der allgemeinen Bevölkerung in Bulgarien: die SMS (Sofia Metabolic Syndrome) Studie. In: Vaskuläre Inflammation und endotheliale Dysfunktion. Heinle H, Schulte H, von Eckardstein A (Hrsg.) Tübingen 2005; 221-225

3. Abstracts in wissenschaftlichen Journals in medline

• Temelkova-Kurktschiev T, Kurktschiev D, Vladimirova-Kitova L, Todorova B. High prevalence of the metabolic syndrome in populations at high and low cardiovascular risk in Bulgaria. European Heart Journal 2009; 30: 658


• Temelkova-Kurktschiev T, Kurktschiev D, Vladimirova-Kitova L, Todorova B. The metabolic syndrome in high-risk and low-risk populations for cardiovascular disease in Bulgaria. Diabetes Stoffwechsel und Herz 2009; 18: 318


• Vekova A, Stefanov Ts, Fredriksson K, Temelkova-Kurktschiev T, Minnaard R. The effect of fatty acid incubation on adipocyte differentiation-related protein, OXPAT, and mitochondrial oxidative phosphorylation protein expression in C2C12 myotubes. Diabetes Stoffwechsel und Herz 2009; 18: 323


• Stefanov T, Vekova A, Schaart G, Temelkova-Kurktschiev T, Hoeks J. Uncoupling protein 3 as a protector against lipid-induced mitochondrial damage. Diabetes Stoffwechsel und Herz 2009; 18: 326


• Kurktschiev D, Vladimirova-Kitova L, Todorova B, Temelkova-Kurktschiev T. Vladimirova-Kitova L, Todorova B, Temelkova-Kurktschiev T. Kardiovaskuläere Risikofaktoren bei Patienten mit Typ 2 Diabetes in Bulgarien. Diabetes Stoffwechsel und Herz 2008; 17: 15


• Temelkova-Kurktschiev T, Koehler C, Henkel E, Schaper F, Kurktschiev D, Hanefeld M. Relationship of fatty liver with increased carotid intima-media thickness. Diabetes Stoffwechsel und Herz 2008; 17: 27


• Lasaviciute S, Vaklinova I, Kurktschiev D, Dasheva D, Griškūnaitė A, Temelkova-Kurktschiev T. Relationship between lifestyle, obesity and type 2 diabetes mellitus: The Sofia Lifestyle study. Diabetes Stoffwechsel und Herz 2008; 17: 15


• Griskuinate A, Vaklinova I, Kurktschiev D, Dasheva D, Staykova T, Temelkova-Kurktschiev T. The level of awareness of type 2 diabetes mellitus among the population of Sofia: The Sofia Lifestyle study. Diabetes Stoffwechsel und Herz 2008; 17: 11


• Temelkova-Kurktschiev T, Koehler C, Henkel E, Schaper F, Hanefeld M. Relationship of liver enzymes with cardiovascular risk factors and carotid intima-media thickness: the RIAD study. Diabetes Stoffwechsel und Herz 2008; 17: 25


• Hahnefeld A, Henkel E, Koehler C, Temelkova-Kurktschiev T, Fischer S, Hanefeld M. Atherosclerosis in iype V hyperlipoproteinemia. A case-control study with 21 matched pairs. Diabetes Stoffwechsel und Herz 2008; 17: 36


• Temelkova-Kurktschiev T. Postprandial hyperglycemia and hyperlipidaemia, inflammation and CVD risk: possible mechanisms. Diabetic Medicine 2006; 23: 34


• Temelkova-Kurktschiev T, Vladimirova-Kitova L, Nikolova M, Todorova B, Kurktschiev D. Prevalence and type of hyperlipidaemia in patients with myocardial infarction, hypertension and type 2 diabetes in Bulgaria. Perfusion 2006; 19: 72


• Temelkova-Kurktschiev T, Vladimirova-Kitova L, Todorova B, Kasabova L, Kurktschiev D. Hohe Prävalenz des Metabolischen Syndroms in Bulgarien: die SMS (Sofia Metabolic Syndrome) Studie. Diabetes und Stoffwechsel 2005; 14: 419


• Gallo S, Leonhardt W, Koehler C, Henkel E, Temelkova-Kurktschiev T, Schaper F, Hanefeld M. The impact of postchallenge plasma glucose on the prevalence of metabolic syndrome, prediabetes and type 2 diabetes. Diabetes und Stoffwechsel 2005; 13(1): 45


• Köhler C, Henkel E, Temelkova-Kurktschiev T, Schaper F, Hanefeld M. The metabolic syndrome adds to increased intima-media thickness of the common carotid arteries in subjects with normal glucose tolerance and newly diagnosed diabetes: the RIAD study. Diabetes und Stoffwechsel 2005; 13 (1): 47


• Temelkova-Kurktschiev T, Kurktschiev D, Vladimirova-Kitova L, Todorova B. The prevalence of Metabolic Syndrome in Bulgaria. Diabetes und Stoffwechsel 2005; 13: 50


• Lademann M, Temelkova-Kurktschiev T, Kurktschiev D, Konzen U, Crusius S, Oberender H, Von Laer G, Reisunger EC. Antibody seroprevalence of tick-borne encephalitis virus (TBE) and Borrelia burgdorferi in humans in and around Sofia, Bulgaria. Infection 2005; 33: 218


• Schwarz PEH, Towers GW, Fücker K, Grässler J, Fischer S, Temelkova-Kurktschiev T, Schulze J, Olckers A, Bornstein SR, Hanefeld M, Vasseur F. APM1 gene haplotypes are linked to pre-existing hypoadiponectinaemia, and through this, to the progression of type 2 diabetes. Diabetes und Stoffwechsel 2005; 13 (1): 41


• Temelkova-Kurktschiev T, Kurktschiev D, Vladimirova-Kitova L, Todorova B. Pulse pressure is an important risk factor for myocardial infarction: the Sofia Metabolic Syndrome (SMS) study. Perfusion 2005; 18 (2): 86


• Vladimirova-Kitova L, Temelkova-Kurktschiev T, Deneva T, Nikolov F. Flow mediated vasodilation and intima-media thickness in asymptomatic patients with familial hypercholesterolemia. Perfusion 2005; 18 (2): 86


• Temelkova-Kurktschiev T, Kurktschiev D, Majdrakova I, Varbanova T, Todorova B. Pulse pressure, an important risk factor for atherosclerosis, is significantly increased in type 2 diabetes: the Sofia Metabolic Syndrome (SMS) study. Diabetologia 2004; 47: A404


• Temelkova-Kurktschiev T, Todorova B, Majdrakova I, Varbanova T, Kurktschiev D. Pulse pressure – an important risk factor for myocardial infarction: the Sofia Metabolic Syndrome (SMS) study. European Heart Journal 2004; 25: 632


• Temelkova-Kurktschiev T, Todorova B, Majdrakova I, Varbanova T, Kurktschiev D. Praevalenz des Typ 2 Diabetes mellitus in der allgemeinen Bevoelkerung in Bulgarien: die SMS (Sofia Metabolic Syndrome) Studie. Diabetes und Stoffwechsel 2004; 13: 148


• Temelkova-Kurktschiev T, Todorova B, Majdrakova I, Varbanova T, Kurktschiev D. Prevalence of the metabolic syndrome in the general population in Bulgaria: the SMS (Sofia Metabolic Syndrome) Study. Diabetes 2004; 53: A256


• Temelkova-Kurktschiev T, Todorova B, Majdrakova I, Varbanova T, Kurktschiev D. Praevalenz des metabolischen Syndroms in der allgemeinen Bevoelkerung in Bulgarien: die SMS (Sofia Metabolic Syndrome) Studie. Perfusion 2004; 17: 93


• Temelkova-Kurktschiev T, Fücker K, Köhler C, Leonhardt W, Hanefeld M. Adiponektin – ein signifikanter unabhängiger Risikofaktor für Intima-Media-Dicke: Die RIAD Studie. Perfusion 2004; 17


• Kurktschiev D, Majdrakova I, Todorova B, Varbanova T, Temelkova-Kurktschiev T. Risikofaktor Hypercholesterinaemie – eine hohe Dunkelziffer in Bulgarien: die SMS Studie. Perfusion 2004; 17: 91


• Majdrakova I, Todorova B, Kurktschiev D, Varbanova T, Temelkova-Kurktschiev T. Hypertension – a common and insufficiently treated disease in Bulgaria. The Sofia Metabolic Syndrome (SMS) study. Perfusion 2004; 17: 9